These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26092526)

  • 21. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
    Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
    Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
    Bayer TA
    Eur Neuropsychopharmacol; 2015 May; 25(5):713-24. PubMed ID: 23642796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].
    Nagai Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):913-6. PubMed ID: 20030247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dawn of protein-folding therapeutics.
    Trapnell BC
    Am J Respir Crit Care Med; 2014 Jan; 189(1):1-3. PubMed ID: 24381984
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular-targeted therapy for neurodegenerative diseases].
    Sobue G
    Rinsho Shinkeigaku; 2009 Nov; 49(11):747-9. PubMed ID: 20030200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex proteinopathies and neurodegeneration: insights from the study of transmissible spongiform encephalopathies.
    Piccardo P; Asher DM
    Arq Neuropsiquiatr; 2018 Oct; 76(10):705-712. PubMed ID: 30427511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives of worldwide translational biomarker research in neurodegenerative diseases.
    Nicotera P; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):496-7. PubMed ID: 21801802
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases.
    Som Chaudhury S; Das Mukhopadhyay C
    Int J Neurosci; 2018 May; 128(5):449-463. PubMed ID: 29076790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
    Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. David Devos.
    Devos D
    Lancet Neurol; 2012 Jul; 11(7):576. PubMed ID: 22710753
    [No Abstract]   [Full Text] [Related]  

  • 32. A quantitative model of human neurodegenerative diseases involving protein aggregation.
    Kepp KP
    Neurobiol Aging; 2019 Aug; 80():46-55. PubMed ID: 31102901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence linking microRNA suppression of essential prosurvival genes with hippocampal cell death after traumatic brain injury.
    Boone DK; Weisz HA; Bi M; Falduto MT; Torres KEO; Willey HE; Volsko CM; Kumar AM; Micci MA; Dewitt DS; Prough DS; Hellmich HL
    Sci Rep; 2017 Jul; 7(1):6645. PubMed ID: 28751711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteostasis therapeutics.
    Garber K
    Nat Biotechnol; 2009 Dec; 27(12):1070. PubMed ID: 20010572
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanisms of recognition and retrotranslocation of misfolded proteins in the ER-associated degradation].
    Nakatsukasa K
    Seikagaku; 2009 Aug; 81(8):700-3. PubMed ID: 19803393
    [No Abstract]   [Full Text] [Related]  

  • 37. Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders.
    Golde TE
    Neuron; 2019 Mar; 101(6):1003-1015. PubMed ID: 30897353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein aggregation and neurodegenerative diseases: From theory to therapy.
    Kumar V; Sami N; Kashav T; Islam A; Ahmad F; Hassan MI
    Eur J Med Chem; 2016 Nov; 124():1105-1120. PubMed ID: 27486076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic approaches of diseases related to misfolded proteins.
    Galons H; Lasmezas C
    Eur J Med Chem; 2016 Oct; 121():773. PubMed ID: 27523642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.